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Abstract We have reported the occurrence of eight splice
variants of rat brain fructose 6-phosphate 2-kinase/fructose 2,6-
bisphosphatase (RB2K). In the present study, we quantified these
splice variants in various tissues using a RNAse protection assay
and found a tissue-specific pattern of alternative splicing of the
RB2K gene. Splice variants containing exon F were specifically
expressed in brain. Moreover, exons D and E were spliced in
brain, skeletal muscle and heart. Consequently, eight, six, four
and two splice variants were expressed in brain, skeletal muscle,
heart and liver plus testis, respectively. These results suggest that
distinct RB2K isoforms could be involved in regulation of
glycolysis in a tissue-specific manner.
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1. Introduction
A bifunctional enzyme, fructose 6-phosphate 2-kinase
(F6P2kinase)/fructose 2,6-bisphosphatase (F26Pase) (EC
2.7.1.105/EC 3.1.3.46), catalyzes the synthesis and degradation
of fructose 2,6-bisphosphate, which is the most potent activa-
tor of phosphofructokinase and plays an important role in
regulation of glycolysis in mammalian tissues [1^3]. Four
mammalian genes of the tissue-speci¢c isozymes of F6P2ki-
nase/F26Pase have been identi¢ed in liver [4,5], heart [6^8],
testis [9] and brain [10^12].
It was reported that the liver, heart and brain isozyme genes
generate multiple isoforms by alternative splicing. The liver
isozyme gene produces liver-type and muscle-type isoforms
that share the same 13 exons and di¡er only by the ¢rst
exon [5]. The ¢rst exon in the liver-type isoform contains a
serine phosphorylated by protein kinase A but not that in the
muscle-type. The F6P2kinase and F26Pase activities of the
liver-type isoform are reciprocally regulated by the phospho-
rylation, which inhibits the former and activates the latter. On
the other hand, the heart isozyme gene generates two isoforms
(58 000 Mr and 54 000 Mr isoforms) through alternative splic-
ing of exon 15, which also encodes a phosphorylation domain
[13,14]. The phosphorylation of the 58 000 Mr isoform by
protein kinase A and C results in activation of the F6P2kinase
without a¡ecting the F26Pase activity [15,16]. However, the
54 000 Mr isoform cannot be phosphorylated by either protein
kinase. In this manner, an alternative splicing mechanism gen-
erates tissue-speci¢c isoforms of which the enzymatic proper-
ties are di¡erent from each other, supporting the idea that the
tissue-speci¢c isoforms are expressed to adapt their enzymatic
properties to metabolic urgency of a particular tissue [12].
Therefore, elucidating of a tissue-speci¢c expression pattern
of the isozyme is important for comprehension of the tissue-
speci¢c regulation mechanisms of glycolysis.
Previously, we reported that eight splice variants (rat brain
F6P2kinase/F26Pase (RB2K) 1^8) are generated in rat brain
from the single primary transcript of the rat brain isozyme
gene [12]. Their variable region of the splice variants is com-
posed of seven exons (exons A^G) and encodes the C-termi-
nus containing consensus phosphorylation sites of protein kin-
ase A and C. We also reported that the gene is expressed in
skeletal muscle, heart, testis and liver. Therefore, we under-
took a detailed analysis of the molecular diversity of the iso-
forms and their tissue distribution in order to gain new in-
sights into the speci¢c implication of this gene in the
regulation of glycolysis.
In this study, we carried out quantitative analysis of the
isoform mRNAs in brain, skeletal muscle, testis, heart and
liver using a RNAse protection assay. We found tissue-speci¢c
regulation of the splicing events of the RB2K gene.
2. Materials and methods
2.1. RNA preparation
Total RNAs were puri¢ed from brain, skeletal muscle, testis, heart
and liver of male Sprague-Dawley rats with guanidium thiocyanate
[17] and poly(A)-RNAs were isolated by subjecting the total RNAs
to oligo(dT)-cellulose column chromatography [18].
2.2. Reverse transcriptase polymerase chain reaction (RT-PCR)
RT-PCR experiments were carried out as described previously [12].
In brief, SuperScript II reverse transcriptase (Gibco BRL) and ran-
dom primers were used to reverse transcribe 10 Wg of poly(A)-RNA
in a 40 Wl reaction mixture. The RNA strand of a RNA-DNA hybrid
was digested by the addition of 2 Wl RNAse H. PCR was carried out
in a total volume of 100 Wl with 2.5 U of Ex Taq polymerase (Takara)
according to the manufacturer, with 200 WM dNTPs, 200 nM of the
appropriate sense and antisense primers and 1 Wl of the ¢rst strand
cDNA. The following primers were used for the ampli¢cation: P1,
5P-GAA CCC CTA CTT CAG CAT CAG-3P ; P2, 5P-CTT CAA
CAG GCA GGA GAC CAA-3P ; P6, 5P-TAC TTG AAT GTA
GAA TCA GTG AGC-3P (Fig. 3). The samples were overlaid with
100 Wl of mineral oil to prevent condensation, placed in a pre-heated
DNA thermal cycler (Astec, Model PC-700) at 94‡C and then sub-
jected to 30 cycles consisting of a 30 s denaturation period at 94‡C, a
30 s annealing period at 60‡C and a 120 s period at 72‡C for extension
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of the annealed primers. After ampli¢cation, the reaction products
were electrophoresed on a 6% polyacrylamide gel.
2.3. Construction of plasmids for protection assay
PCR was performed with oligonucleotides 5P-GTA GGA TCC
GTG AGC ACG CAT CGG-3P (BamHI sense primer) and 5P-GGA
GAA TTC GGC ACC GCT CCG GGG-3P (EcoRI antisense primer
1) with each of the RB2K1, RB2K2, RB2K3 and RB2K4 cDNAs
[12] as a template to amplify a fragment consisting of the variable
region of the RB2K £anked by the BamHI and EcoRI sites. In the
case of the synthesis of a fragment for RB2K7, an oligonucleotide
5P-GTG GAA TTC AAG CAA TGG AAT TAT-3P (EcoRI antisense
primer 2) was used instead of the EcoRI antisense primer 1. These
ampli¢ed fragments were digested with BamHI and EcoRI and ligated
into the BamHI/EcoRI sites of pSP72 (Promega). The resulting plas-
mids were linearized with BamHI or EcoRI and used as templates to
synthesize the antisense RNA probes or sense RNA standards, respec-
tively.
2.4. RNAse protection assays
Antisense RNA probes and sense RNA standards were synthesized
with T7 and SP6 polymerases, respectively. RNAse protection assays
were carried out according to Sambrook et al. [18]. The radiolabelled
probe was incubated with 5 Wg of poly(A)-RNA or varying amounts
of the sense RNA standard (0, 1, 5 or 10 pg) for 16 h at 45‡C. Yeast
tRNA was added to the sense RNA samples to bring the RNA total
to 5 Wg and the samples were then treated with RNAse A (40 Wg/ml)
(Sigma) and RNAse T1 (2 Wg/ml) (Boehringer Mannheim). The pro-
tected fragments were isolated and electrophoresed on a 6% poly-
acrylamide sequencing gel.
3. Results
3.1. Detection of tissue-speci¢c alternative splicing of RB2K
mRNA using RT-PCR
To evaluate the extent of RB2K isoform diversity, we car-
ried out a RT-PCR experiment using mRNAs isolated from
various tissues. Three PCR primers were designed to amplify
the cDNA coding the C-terminus of RB2K. A primer pair (P1
and P6) ampli¢es DNA fragments derived from the RB2K1^
RB2K6 mRNAs. Another primer pair (P2 and P6) ampli¢es
those of RB2K7 and RB2K8. The RT-PCR detected eight,
four and two RB2K isoforms in brain, skeletal muscle and the
other tissues, respectively (Fig. 1). RB2K1 and RB2K4, which
contains exon F, were exclusively expressed in brain. RB2K2,
RB2K5, RB2K7 and RB2K8 that use exon D occurred in
both brain and skeletal muscle. RB2K3 and RB2K6 were
found in brain, heart, liver and testis. These data indicate
that the primary transcript of the gene is processed by tis-
sue-speci¢c alternative splicing.
3.2. RNAse protection assay
To assess the splicing e⁄ciency of the alternative exons
quantitatively, RNAse protection assays were performed
with the isoform-speci¢c antisense RNAs. Five RNA probes
were chosen for these experiments so as to generate similar
size protected fragments and to detect all possible coding re-
gion splice variants. Using the antisense RB2K1 probe, pro-
tected fragments of 395, 312, 311, 288 and 283 nucleotides
(nt), which arise from the respective mRNAs of RB2K1,
RB2K2, RB2K7, RB2K3 and RB2K4, were observed.
RB2K1 was found in only brain and was not detected in all
the other tissues examined (Fig. 2A). However, fragments of
312 nt as well as 311 and 288 nt as well as 283 nt co-migrated.
To detect another brain-speci¢c isoform (RB2K4), hybridiza-
tion with the antisense RB2K4 probe was carried out. The
assay resulted in a protected fragment of 308 nt found in
only brain (Fig. 2B). These results demonstrate that RB2K1
and RB2K4 were expressed exclusively in brain.
The protected fragments of 342 and 230 nt corresponding
to RB2K2 and RB2K5, respectively, were manifested in brain
and skeletal muscle with the use of the antisense RB2K2
probe (Fig. 2C). These isoforms contain the sequence encoded
by exon D. Even with prolonged exposures, no fragments
were detected in heart, liver or testis.
The tissue distributions of the RB2K isoforms as deter-
mined by the RNAse protection analysis are so far in good
agreement with the RT-PCR analysis. However, fragments of
319 and 207 nt protected by the antisense RB2K3 probe,
which arise from the respective RB2K3 and RB2K6 mRNAs,
were observed in all the tissues examined (Fig. 2D). The ex-
pression of RB2K3 and RB2K6 in skeletal muscle cannot be
detected by the RT-PCR method (Fig. 1), although signi¢cant
amounts of the mRNAs were detected by the RNAse protec-
tion assay. Moreover, 341 and 229 nt fragments, which cor-
respond to the respective mRNAs of RB2K7 and RB2K8,
were observed in not only brain and skeletal muscle but
also in heart (Fig. 2E). The occurrence of RB2K7 and
RB2K8 in heart also cannot be detected by RT-PCR. The
discrepancy between the results obtained using the RT-PCR
method and the RNAse protection assay to detect the expres-
sion of these isoforms re£ects the di¡erence in the detection
limit of these two methods.
The amounts of the RB2K mRNAs were determined by
quantitative scanning densitometry, within the linear range
of ¢lm sensitivity of the autoradiographic signals of the
RNAse protection assay (Table 1). All RB2K mRNAs were
expressed at comparable levels to each other in these rat tis-
sues. The total amount of RB2K isoforms in each tissue as
determined by the RNAse protection assay is in good agree-
ment with the tissue distribution of the RB2K analyzed by the
Northern blot (cf. Fig. 1 of [12]).
4. Discussion
This study describes the tissue-speci¢c alternative splicing
events of the RB2K gene. As summarized in Fig. 3, exons D^
Fig. 1. RT-PCR analysis of alternatively spliced RB2K mRNAs.
Poly(A)-RNA from each of the indicated rat tissues was reverse-
transcribed and used for PCR analysis as described in Section 2.
The products of the PCR reaction were separated by electrophoresis
on a 6% polyacrylamide gel and stained with ethidium bromide. P1
and P2 primers were designed to amplify the C-terminal coding re-
gion of RB2K1^RB2K6 and RB2K7 plus RB2K8, respectively. The
origins of the poly(A)-RNAs were as follows: (B) brain, (M) skele-
tal muscle, (T) testis, (H) heart and (L) liver.
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Fig. 2. RNAse protection analysis of RB2K expression in rat tissues. A: Poly(A)-RNA (5 Wg) from rat tissues or sense standard RNA (1, 5
or 10 pg) was hybridized to a RB2K1-speci¢c antisense RNA probe, treated with RNAse and separated by denaturing gel electrophoresis. The
position of the RNA probe is indicated on the left and the positions of the tissue RNA-protected fragments are indicated on the right. RNAs
in the lanes were as follows: (C) tRNA as negative control (5 Wg), (B) brain, (T) testis, (L) liver, (M) skeletal muscle, (H) heart, (P) antisense
RNA probe, (1, 5, 10 pg) sense RNA probes, (1+4) the mixture of sense RNAs of RB2K1 and RB2K4, (1^6) the mixture of sense RNAs of
RB2K1^6. B^E: These are the same experiments with use of RB2K4-, RB2K2-, RB2K3- and RB2K7-speci¢c probes, respectively. Size marker
lanes containing sense RNAs are as follows: (1+4), (2+5), (3+6) and (7+8) are the mixtures of the sense RNAs of RB2K1 plus RB2K4,
RB2K2 plus RB2K5, RB2K3 plus RB2K6 and RB2K7 plus RB2K8, respectively.
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F were spliced in a tissue-speci¢c manner. Exon F was ex-
pressed in only brain. In the other tissues, it was spliced out
from the primary transcript of the gene. Exon D and exon E
are not divided by an intron structure. Moreover, a consensus
sequence of a donor site of an intron is observed at the 5P-end
of exon E [12]. These two exons were expressed not only in
brain and skeletal muscle but also in heart (Fig. 2). In heart,
however, the two alternative exons were always spliced to-
gether and behaved like a single exon. It implies that spliceo-
somes of heart cannot recognize the sequence of the donor site
of exon E. These results suggest that tissue-speci¢c factors
interacting with speci¢c cis-elements of the gene regulate the
alternative splicing.
It has been reported that counterparts of the RB2K5 and
RB2K6 isoforms are expressed in bovine and human tissues.
Ventura et al. reported the partial cDNA sequence of bovine
brain F6P2kinase/F26Pase that is a counterpart gene of
RB2K [11]. The alignment analysis shows that the bovine
cDNA sequence lacks exon B and terminates at the middle
of exon C. Therefore, the cDNA of the bovine brain isozyme
may be one of the counterparts of RB2K4, 5, 6 and 8. A
counterpart of the RB2K6 isoform is expressed in human
placenta and breast cancer cells [19,20]. Hamilton et al. re-
ported that progestin induces the RB2K6 counterpart gene in
human breast cancer cell lines [20]. They quanti¢ed the ex-
pression of the gene using a Northern blot with a cDNA
probe, which is derived from the invariant region of the
cDNA. Therefore, they did not observe the isoform-speci¢c
induction of the gene. Recently, Chesney et al. reported that a
counterpart of RB2K5 is expressed in several human cancer
cell lines and is induced by pro-in£ammatory stimuli [21]. The
induction of the counterparts of RB2K5 and RB2K6 in the
cancer cell lines by the respective stimuli of the lipopolysac-
charide and progestin is very interesting, implying coupling of
enhanced glycolysis and cell proliferation.
RT-PCR is a sensitive and simple method to detect mRNA,
although the methodology has a problem of poor reliability of
quantitative measurement of mRNA. The method detected
tissue-speci¢c alternative splicing of the RB2K gene (Fig. 1).
However, it failed to detect the occurrence of RB2K3 plus
RB2K6 in skeletal muscle and RB2K7 plus RB2K8 in heart
(Fig. 2D,E). There are several factors that a¡ect the reliability
of the method. In this case, it seems likely that the e⁄ciency
of the PCR ampli¢cation or the reverse transcription may
become a limiting factor, because the undetectable fragments
appeared as weak bands after RT-PCR with 40 ampli¢cation
cycles instead of 30 (data not shown).
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